Some digital health companies billing Medicare for recurring care management services are facing payment suspensions amid increased federal scrutiny of billing practices. Proposed 2027 reimbursement changes could further affect revenue sustainability, clinical operating costs, and the economics of digital health business models.
At a Glance
$500M+ in Medicare Remote Physiologic Monitoring (RPM) payments: Medicare payments exceeded $500 million in 2024.
43% of RPM beneficiaries: A federal review identified gaps in remote monitoring service delivery and billing oversight.
2027 Medicare proposals: CMS is reviewing reimbursement valuations, clinical staffing requirements, and monitoring billing structures.
1. Medicare Reimbursement Has Expanded Digital Health Commercialization
AI is reducing software development costs and improving operating efficiency, while Medicare reimbursement provides additional commercialization opportunities beyond subscriptions and out-of-pocket payments.
Three care management and monitoring categories support recurring reimbursement for eligible clinical services:
Chronic Care Management (CCM): Monthly reimbursement for coordinating care for patients with multiple qualifying chronic conditions.
Remote Physiologic Monitoring (RPM): Reimbursement for physiologic monitoring, including blood pressure and weight, alongside qualifying device and clinical management services.
Remote Therapeutic Monitoring (RTM): Reimbursement for monitoring treatment adherence, therapeutic response, and related clinical management activities.
These pathways enable providers to generate recurring revenue from ongoing patient care rather than relying exclusively on episodic encounters.
Medicare RPM payments exceeded $500 million in 2024. Historical CMS data cited in the research report also indicates that only 4% of approximately 22.6 million clinically eligible Medicare fee-for-service beneficiaries received CCM services, suggesting opportunities for increased utilization.
2. CMS Scrutiny is Reshaping Reimbursement and Clinical Operating Requirements
Federal regulators are increasing oversight of Medicare care management and monitoring services, focusing on patient eligibility, service delivery, and billing accuracy.
A 2024 Health and Human Services Office of Inspector General (HHS-OIG) review identified service delivery gaps affecting approximately 43% of RPM beneficiaries. In March 2026, HHS-OIG added CCM payments to its audit work plan, focusing on beneficiary eligibility.
Separately, CMS proposed changes under its Calendar Year (CY) 2027 Medicare Physician Fee Schedule (PFS).
Key Regulatory Proposals and Enforcement Developments
Clinical Staffing: CMS proposes limiting reimbursement for certain RPM and RTM activities to clinical staff directly employed by the billing practice. Outsourced monitoring providers could face operating model restructuring, while software-only vendors generally have less direct exposure.
Patient Initiation: Proposed requirements include a separately reportable initiating visit for RPM and RTM and restrictions on RTM services for new patients, potentially increasing onboarding costs.
Reimbursement Valuations: CMS proposes revising practice expense valuations for remote monitoring, potentially affecting reimbursement per patient and gross margins.
Billing Code Consolidation: CMS is considering replacing 17 RPM and RTM codes with four bundled HCPCS G-codes. GRPM1/GRTM1 would cover initial setup, while GRPM2/GRTM2 would combine monthly device supply, transmission, and clinical management. The contemplated monthly codes require at least 20 minutes of treatment management and real-time patient interaction, potentially limiting separate device supply reimbursement.
Enforcement and Payment Recovery: Regulatory scrutiny creates exposure to claim reviews, payment suspensions, and recoveries. In June 2026, Circle Medical and related parties agreed to a $3.3 million settlement involving allegations of improper provider billing, without a determination of liability. Separately, CMS has proposed expanded retroactive Medicare enrollment revocation and payment recovery authority.
Regulatory Status: The staffing, initiation, valuation, and enrollment enforcement changes remain proposals. Code consolidation is under consideration through a request for comments. None of these proposed changes are finalized as of October 16, 2026.
3. Financial and Operating Implications for Digital Health
Revenue Quality and Concentration: Companies reliant on a narrow set of CPT codes face greater regulatory exposure, making reimbursement realization, denial rates, and revenue concentration important underwriting metrics.
Clinical Operating Costs and Gross Margins: AI reduces administrative costs but does not eliminate clinical staffing and supervision requirements. Proposed restrictions on outsourced personnel could increase fixed labor costs, compress gross margins, and constrain operating leverage.
Customer Acquisition and Patient Economics: Reimbursement eligibility and clinical onboarding affect customer acquisition cost (CAC), lifetime value (LTV), and payback periods. Enrollment growth may not translate into proportional revenue growth, making collections per qualifying patient, retention, and contribution margins important measures of unit economics.
Working Capital and Cash Flow: Payment delays, claim reviews, suspensions, and potential clawbacks can disrupt liquidity, particularly for Medicare-dependent businesses.
AI Efficiency Versus Clinical Delivery Requirements
Julie Yoo, General Partner at a16z, highlighted the continuing commercialization requirements in a StartUp Health podcast, noting that faster product development does not eliminate the need to:
“build a sales force, distribute to the market, to integrate”
Yoo specifically cited Epic integration as a persistent commercialization challenge despite improvements in software development efficiency.
For reimbursement-dependent businesses, technology scalability does not necessarily translate into clinical service scalability. Operating leverage remains tied to clinical delivery costs, provider relationships, and reimbursement requirements.
4. The Changing Investment Framework for Digital Health
Funding remained concentrated in larger rounds, with financings of $100 million or more accounting for 45% of total funding in 1H 2026. According to Rock Health, U.S. digital health startups raised $7.4 billion across 244 transactions during the period, compared with $6.4 billion across 245 transactions in 1H 2025.
Point Solutions Versus Integrated Platforms:Companies dependent on a limited number of reimbursement codes face greater revenue concentration risk. Integrated platforms may diversify revenue across clinical services, software subscriptions, and payer contracts, although additional reimbursement categories can introduce greater operating and regulatory complexity.
Capital Markets Outlook
AI is expanding digital health commercialization opportunities, while increasing Medicare scrutiny introduces reimbursement uncertainty. For investors, revenue quality, regulatory exposure, operating margins, and cash flow sustainability remain central to financing, valuation, and strategic transactions.
Sources